Continuous motion monitoring sensitively predicts terminal endpoint in a mouse model of ovarian cancer; the use of motion metrics could reduce animal suffering and be valuable for drug efficacy testing.
- Chibueze D. Nwagwu
- Erwin Defensor
- W. Shawn Carbonell
